Research

Adherence

Current clinical guidelines recommend individualized perioperative management for GLP-1 RA users, with recent consensus shifting from mandatory discontinuation to risk-based assessment based on gastrointestinal symptoms and treatment duration.

Do not stop your GLP-1 medication on your own before surgery. Recent guidelines say you should likely keep taking it unless you have severe nausea or vomiting. Your surgical team will create a specific plan for you, possibly adjusting your fasting rules, to keep your blood sugar stable while minimizing lung risks.

GoodSupportsHIGH confidence
Current preoperative assessment for patients treated with GLP-1 RAs emphasizes individualized evaluation based on the route of administration, duration of therapy, and presence of gastrointestinal symptoms, suggesting that tailored management according to patient-specific risk is more appropriate than a uniform prolongation of fasting periods.
Donghee Kang et al. · The Korean Journal of Internal Medicine · 2026

Why this rating

Based on consensus statements from major anesthesia societies (ASA, BJA).

Source

Delayed gastric emptying induced by glucagon-like peptide-1 receptor agonists and its implications for perioperative risk during anesthesia

Donghee Kang et al. · The Korean Journal of Internal Medicine · 2026

DOI 10.3904/kjim.2025.277

narrative_review
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →